BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10822876)

  • 1. Reactive oxygen species and antioxidant status in essential arterial hypertension during therapy with dihydropyridine calcium channel antagonists.
    Digiesi V; Fiorillo C; Cosmi L; Rossetti M; Lenuzza M; Guidi D; Pace S; Rizzuti G; Nassi P
    Clin Ter; 2000; 151(1):15-8. PubMed ID: 10822876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reactive metabolites of oxygen, lipid peroxidation, total antioxidant capacity and vitamin E in essential arterial hypertension].
    Digiesi V; Oliviero C; Giannò V; Rossetti M; Fiorillo C; Oradei A; Lenuzza M; Nassi P
    Clin Ter; 1997 Nov; 148(11):515-9. PubMed ID: 9494252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined effect of calcium channel blocker Lercanidipine and antioxidants on low-grade systemic inflammation parameters in essential hypertension patients.
    Farah R; Shurtz-Swirski R
    Minerva Cardioangiol; 2008 Oct; 56(5):467-76. PubMed ID: 18813182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis.
    Allanore Y; Borderie D; Lemaréchal H; Ekindjian OG; Kahan A
    Am J Med; 2004 May; 116(9):595-600. PubMed ID: 15093755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benidipine, a long-acting calcium channel blocker, inhibits oxidative stress in polymorphonuclear cells in patients with essential hypertension.
    Yasunari K; Maeda K; Nakamura M; Watanabe T; Yoshikawa J
    Hypertens Res; 2005 Feb; 28(2):107-12. PubMed ID: 16025736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
    Matsubara M; Akizuki O; Ikeda J; Saeki K; Yao K; Sasaki K
    Eur J Pharmacol; 2008 Feb; 580(1-2):201-13. PubMed ID: 18048030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypertension with dihydropyridine calcium antagonists and aspirin.
    Tison P; Ulicna L; Jakubovska Z; Oravcova J; Fetkovska N
    Blood Press Suppl; 1994; 1():57-60. PubMed ID: 8205303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of benidipine hydrochloride on 24-hour blood pressure and blood pressure response to mental stress in elderly patients with essential hypertension.
    Muneta S; Kohara K; Hiwada K
    Int J Clin Pharmacol Ther; 1999 Mar; 37(3):141-7. PubMed ID: 10190762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen-free radical decrease in hypertensive patients treated with lercanidipine.
    Incandela L; Belcaro G; Cesarone MR; De Sanctis MT; Griffin M; Cacchio M; Nicolaides AN; Bucci M; Barsotti A; Martines G; Cornelli U; Di Renzo A
    Int Angiol; 2001 Jun; 20(2):136-40. PubMed ID: 11533521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in patients with essential hypertension.
    Tandon R; Sinha MK; Garg H; Khanna R; Khanna HD
    Natl Med J India; 2005; 18(6):297-9. PubMed ID: 16483028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of calcium channel blocker lercanidipine on lowgrade inflammation parameters in essential hypertension patients].
    Shurtz-Swirski R; Farah R; Sela S; Shapiro G; Klempef R; Snitkovski T; Kristal B
    Harefuah; 2006 Dec; 145(12):895-9, 942. PubMed ID: 17220028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker.
    Sanada H; Midorikawa S; Yatabe J; Yatabe MS; Katoh T; Baba T; Hashimoto S; Watanabe T
    Hypertens Res; 2005 Nov; 28(11):871-8. PubMed ID: 16555575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of lercanidipine in the general practice setting].
    Robles NR; Canelada JA; Iglesias M; Angulo E; López Acedo A; Díaz Olea E; Cidoncha F; Guerras M; Fuentes J; Garrido J; Lapie J; Peña J; Aguilar A; Hidalgo P
    An Med Interna; 2003 Jun; 20(6):282-6. PubMed ID: 12848597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of lacidipine, a novel dihydropyridine calcium antagonist, on carbohydrate and lipid metabolism.
    Spieker C; Zidek W
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S23-6. PubMed ID: 8852541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal-protective effect of T-and L-type calcium channel blockers in hypertensive patients: an Amlodipine-to-Benidipine Changeover (ABC) study.
    Ohishi M; Takagi T; Ito N; Terai M; Tatara Y; Hayashi N; Shiota A; Katsuya T; Rakugi H; Ogihara T
    Hypertens Res; 2007 Sep; 30(9):797-806. PubMed ID: 18037772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
    Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
    Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lercanidipine vs lacidipine in isolated systolic hypertension.
    Millar-Craig M; Shaffu B; Greenough A; Mitchell L; McDonald C
    J Hum Hypertens; 2003 Nov; 17(11):799-806. PubMed ID: 14578921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.